Biotech · Private company
Treeline Biosciences, Inc.
Track this companyFree. Adds Treeline Biosciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials33 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- TLN-121Phase 1 · LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- TLN-254Phase 1 · LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- TLN-372Phase 1 · KRAS Mutant Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- TLN-372 in combination with cetuximabPhase 1 · KRAS Mutant Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- TLN-372 in combination with pembrolizumabPhase 1 · KRAS Mutant Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- zeprumetostat (TLN-254)Phase 1 · LymphomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- TLN-372 in Advanced KRAS Mutant Solid TumorsPHASE1 · RECRUITING · started Sep 29, 2025ClinicalTrials.gov NCT07204340 · fetched Nov 12, 2026
- TLN-121 in Relapsed or Refractory Non-Hodgkin LymphomasPHASE1 · RECRUITING · started Jun 23, 2025ClinicalTrials.gov NCT07082803 · fetched Nov 12, 2026
- A Study of TLN-254 in Participants With Relapsed or Refractory T-cell LymphomaPHASE1 · ACTIVE_NOT_RECRUITING · started Dec 16, 2024ClinicalTrials.gov NCT06733441 · fetched Nov 12, 2026